Skip to main content
. 2024 Nov 22;14:29013. doi: 10.1038/s41598-024-79909-8

Fig. 4.

Fig. 4

Prolonged elevation of chemokines MCP1, ITAC, and MIP-3β in SARS-CoV-2 and HCV patients. In SARS-CoV-2 cohort 2, MCP1, ITAC and MIP-3β levels initially decline, before increasing again. In HCV patients, SIM levels decrease compared to healthy controls but remain elevated, with significant discrepancies in concentration levels depending on the stage of HCV infection. Measurements are shown as mean with its standard error. Kruskal–Wallis with Dunn’s correction has been used for the healthy donors and the different cohorts at T1 and the last follow-up. Two-tailed P values < 0.05 (*), < 0.01 (**), < 0.001 (***) and < 0.0001 (****) were considered significant.